Filing Details
- Accession Number:
- 0001104659-19-047352
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-26 21:49:19
- Reporting Period:
- 2019-08-22
- Accepted Time:
- 2019-08-26 21:49:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1641640 | Nabriva Therapeutics Plc | NBRV | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1711517 | Maria Francesco Lavino | 1000 Continental Drive Suite 600 King Of Prussia PA 19406 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2019-08-22 | 4,800 | $2.04 | 15,972 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reporting person's purchase of ordinary shares of Nabriva Therapeutics plc (the "Issuer") reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 4,800 shares, with the reporting person's sale of 3,797 ordinary shares at a price of $2.08 per share on August 21, 2019. The reporting person has agreed to pay to the Issuer $204, representing the full amount of the profit realized in connection with the short-swing transaction.
Billionaire Hedge Funds
